Although CTLA-4 ICB-mediated depletion of tumour-infiltrating regulatory T cells has not been observed in human cancers such as melanoma, prostate and bladder cancers, an increase in tumour-infiltrating CD4+ and CD8+ cells has been reported [30]. This evidence concerns the gene CTLA4 and cancer.